Does the IL6 rs1800795 (−174G>C) variant affect IL-6 expression and systemic inflammation?

Interleukin-6 (IL-6) is a pivotal cytokine that bridges innate and adaptive immunity, acting as a primary driver of the systemic acute-phase response. The rs1800795 (−174G>C) polymorphism in the IL-6 gene promoter is a well-characterized genetic variant that directly influences how individuals respond to inflammatory stimuli.

Clinical and inflammatory evidence

Research consistently demonstrates that the rs1800795 genotype is a significant determinant of inter-individual variability in systemic inflammation.

• Genotype-specific surges: While basal levels of IL-6 may differ only subtly, the G allele is associated with a markedly heightened surge in circulating IL-6 protein following inflammatory triggers (e.g., infection or tissue injury) compared to the C allele.
• Downstream markers: Because IL-6 is the primary stimulus for the hepatic production of C-reactive protein (CRP), individuals with the GG genotype often exhibit higher circulating levels of high-sensitivity CRP (hsCRP) during inflammatory states.
• Disease associations: This differential inflammatory profile has clinical consequences; the polymorphism is linked to varying susceptibility and severity in conditions driven by inflammation, including coronary artery disease, juvenile idiopathic arthritis, and the severity of COVID-19.

Mechanistic explanations

The influence of rs1800795 on inflammation is rooted in its role as a functional regulator of gene transcription.

• Transcriptional activity: The G allele enhances the binding affinity of key transcription factors, such as NF-IL6 and the glucocorticoid receptor, to the IL-6 promoter. This results in significantly higher transcriptional activity and mRNA expression compared to the C allele.
• Cell-type specificity: Gene reporter assays indicate that this effect is highly cell-type dependent. The G allele's drive toward higher expression is particularly robust in fibroblasts—major IL-6 producers during inflammation—whereas the effect may be negligible in other cell types like monocytes.

Bottom line

The IL6 rs1800795 (−174G>C) polymorphism is a functional genetic variant where the G allele promotes higher transcriptional activity and increased circulating IL-6 levels. This variation directly contributes to inter-individual differences in the magnitude of systemic inflammatory responses and downstream markers like CRP.